| Financial Year |
March 31 2023 |
| Monetary Funds |
169,761,628.82 |
| Held-for-trading Financial Assets |
96,439,900.25 |
| Notes Receivable |
1,498,125.30 |
| Accounts Receivable |
56,884,777.62 |
| Advances to Suppliers |
18,792,648.89 |
| Other Receivables |
67,939,049.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
258,597,107.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,673,239.30 |
| Total Current Assets |
674,000,467.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
277,524,797.15 |
| Investment Properties |
-- |
| Fixed Assetes |
114,707,075.43 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,304,754.56 |
| R&D expenses |
-- |
| Goodwill |
123,650,837.79 |
| Long-Term Deferred and Prepaid Expenses |
17,001,740.59 |
| Deferred Income Tax Assets |
25,224,708.56 |
| Other Non-Current Assets |
63,659,891.71 |
| Sub-Total of Non-Current Assets |
694,733,334.73 |
| Total Assets |
1,368,733,802.07 |
| Short-Term Loans |
191,450,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
58,974,071.62 |
| Accounts Received In Advance |
254,645,857.47 |
| Employee Compensation Payable |
24,433,687.37 |
| Taxes Payable |
32,013,628.04 |
| Interest Payable |
-- |
| Dividend Payable |
3,272,541.95 |
| Other payables |
35,585,148.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,651,760.83 |
| Other Current Liabilities |
2,822,052.52 |
| Sub-Total of Current Liabilities |
643,752,900.38 |
| Long-term Loans |
11,301,403.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
82,311.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,818,360.50 |
| Total Liabilities |
713,571,260.88 |
| Paid-In Capital(Or Share Stock) |
360,000,000.00 |
| Capital Surplus |
179,735,319.41 |
| Surplus Reserve |
38,185,489.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
46,590,030.53 |
| Minority Stockholder's Interest |
30,651,701.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
624,510,839.31 |
| Owner's Equity（Stockholder's Equity） |
655,162,541.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,368,733,802.07 |
